MoneyWorks4Me

Windlas Biotech informs about notice of postal ballot

19 Feb 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Schedule III of the said Regulations, Windlas Biotech has enclosed a copy of the Notice of Postal Ballot dated February 11, 2025, seeking approval of the Members of the Company, through Postal Ballot (through remote e-voting only) for re-appointment of Hitesh Windlass (DIN: 02030941) as Managing Director and Manoj Kumar Windlass as (DIN:00221671) as Joint Managing Director of the Company with effect from April 30, 2025.
The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1858.20
Dr. Reddys Labs. 1155.55
Cipla 1359.00
Lupin 2060.00
Zydus Lifesciences 1110.20
View more..